DEA Archived Press Releases

Press Releases before January 20, 2025
9 Results - Showing 1 to 9
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

LYNCHBURG, Va. – A Madison Heights, Virginia man, and former veterinarian, pleaded guilty to a pair of drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to the adulteration of a drug held...
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
PRESS RELEASE

Physician Assistant Sentenced for Conspiring to Distribute and Dispense Oxycodone, Fentanyl, Methadone, and Alprazolam

Baltimore, Md., – U.S. District Judge Richard D. Bennett sentenced William Soyke, age 68, of Hanover, Pennsylvania to 37 months in federal prison, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone, fentanyl, methadone, and alprazolam outside the scope of professional practice and not for...
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
PRESS RELEASE

DEA Washington Launches New Conference Series to Work with Healthcare Professionals & Help End the Overdose Crisis

The DEA Washington Division, an agency currently working to expand partnerships to offer targeted, full-scope solutions for the drug problems in Maryland, Washington DC, and Virginia, today introduced a new webinar series, “Empowering DMV Healthcare Professionals.” The idea for this unique concept was crystalized during the pandemic, when overdose rates...
PRESS RELEASE

Former Roanoke pharmacist sentenced for tampering with powerful narcotics

ROANOKE, Va. – Bryan Wade Lewis, a former pharmacist at Home Choice Partners in Roanoke, was sentenced yesterday in U.S. District Court for tampering with a consumer product, hydromorphone, that affected interstate commerce. Jarod Forget, Special Agent in Charge of the DEA's Washington Division and Acting United States Attorney Daniel...